MSFP
IPSC icon

Mark Sheptoff Financial Planning’s Century Therapeutics IPSC Stock Holding History

Mark Sheptoff Financial Planning’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15K Hold
500
– – ﹤0.01% 483
2025
Q4 		$497 Hold
500
– – ﹤0.01% 492
2025
Q3 		$249 Hold
500
– – ﹤0.01% 472
2025
Q2 		$279 Hold
500
– – ﹤0.01% 503
2025
Q1 		$238 Hold
500
– – ﹤0.01% 436
2024
Q4 		$505 Hold
500
– – ﹤0.01% 416
2024
Q3 		$855 Buy
+500
New +$980 ﹤0.01% 407

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Mark Sheptoff Financial Planning's IPSC Position: Q1 2026 in Review

Mark Sheptoff Financial Planning held its Century Therapeutics (IPSC) position steady in Q1 2026 at 500 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #483.

Mark Sheptoff Financial Planning first reported a position in IPSC in Q3 2024 and has held it in 7 quarters since. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Mark Sheptoff Financial Planning held 500 shares of Century Therapeutics worth $1.15K as of Q1 2026.
  • Mark Sheptoff Financial Planning left its Century Therapeutics share count unchanged in Q1 2026.
  • Century Therapeutics made up ﹤0.01% of Mark Sheptoff Financial Planning's portfolio in Q1 2026, its #483 holding.
  • Mark Sheptoff Financial Planning first reported a position in Century Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2026, filed 11 May 2026.